Willis Towers Watson Public Limited Company Ordinary Shares
WTW
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.
Last trade$334.02
Day change-$4.115 (-1.22%)
Day range$332.30 – $338.13
Volume204,571
Market cap$31.18B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$31.18B
Price / earnings
19.94×
Price / book
4.02×
Price / sales
3.03×
EV / sales
3.48×
EV / EBITDA
12.55×
Profitability
Earnings per share
$16.96
Return on assets
5.21%
Return on equity
20.14%
Dividend yield
1.14%
Liquidity and leverage
Debt / equity
0.84×
Current ratio
1.1×
Quick ratio
1.1×
Cash ratio
0.13×
Cash flow
Price / cash flow
15.72×
Price / free cash flow
17.89×
Free cash flow
$1.74B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for WTW, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$2.46B
$2.47B
$2.41B
$2.94B
$2.29B
$2.26B
$2.22B
$3.04B
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$2.46B
$2.47B
$2.41B
$2.94B
$2.29B
$2.26B
$2.22B
$3.04B
Selling, general and administrative
$1.51B
$1.55B
$1.43B
$1.44B
$1.41B
$1.45B
$1.32B
$1.37B
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$2.03B
$2.1B
$1.96B
$1.92B
$1.87B
$1.89B
$1.79B
$2.13B
Operating income
$429M
$364M
$448M
$1.02B
$418M
$368M
$432M
$901M
Interest expense
-$80M
-$78M
-$77M
-$66M
-$65M
-$64M
-$65M
-$66M
Income before taxes
$401M
$288M
$373M
$947M
$390M
$311M
$304M
$1.69B
Income taxes
$79M
$57M
$70M
$197M
$77M
-$21M
$65M
$440M
Net income
$309M
$231M
$303M
$736M
$306M
$332M
$239M
$1.25B
Net income attributable to common shareholders
$303M
$229M
$297M
$735M
$304M
$331M
$235M
$1.25B
EBITDA
$599M
$535M
$593M
$1.12B
$523M
$476M
$534M
$1.04B
Basic earnings per share
$3.25
$2.43
$3.12
$7.69
$3.12
$3.34
$2.34
$12.46
Diluted earnings per share
$3.24
$2.43
$3.10
$7.58
$3.11
$3.32
$2.33
$12.59
Recent news
Company coverage with links to the original publishers.
Marsh & McLennan Companies has agreed to acquire Wilshire, a global investment advisory firm managing $221 billion in assets and advising on $1.6 trillion in client assets. The acquisition, expected to close in Q1 2027, aims to expand Marsh's wealth business, strengthen institutional investment offerings, and diversify fee-based revenues through cross-selling opportunities.
Marsh & McLennan's Management Consulting segment showed strong 14% revenue growth in Q3 driven by AI-related projects, but the company expects roughly flat Q4 revenues as some success fees were pulled forward. The broader Consulting segment posted 8% underlying growth with 9% adjusted operating income rise. While near-term slowdown is expected, strong positioning in AI advisory services and solid year-to-date performance could support future earnings growth.
Zacks analyzes four insurance brokerage stocks, highlighting industry tailwinds from better pricing, rising demand, and consolidation. While the industry faces near-term headwinds with a bottom-21% ranking, individual stocks show varied prospects. Erie Indemnity carries a Buy rating, while Willis Towers Watson, Arthur J. Gallagher, and Brown & Brown hold Hold ratings. The broader insurance brokerage market is projected to grow from $359.27 billion in 2026 to $572.47 billion by 2031.
Zacks Research Daily features analysis of 16 major stocks on November 6, 2026. Shell benefits from LNG expansion and capital efficiency with an Outperform rating. Dell significantly outperforms its industry driven by AI and data-center demand. Amphenol gains from high-speed interconnect products and AI-related programs. Among other stocks analyzed, NIKE faces weak demand and margin pressures, while Diamondback Energy benefits from higher oil output and increased production guidance.
Marsh & McLennan Companies has introduced BrightPath, a globally coordinated defined-contribution retirement solution spanning six markets with $116 billion in AUM. The platform combines investment expertise, delegated governance, and digital tools for multinational employers. While the initiative could generate additional fees and strengthen MRSH's market position, the company has not disclosed revenue targets or earnings contributions. MRSH shares have gained 9.8% year-to-date and carry a Zacks Rank #3 (Hold) with projected 2026 earnings growth of 7.5%.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Sep 30, 2026
$0.96
Oct 15, 2026
recurring
Jun 30, 2026
$0.96
Jul 15, 2026
recurring
Mar 31, 2026
$0.96
Apr 15, 2026
recurring
Dec 31, 2025
$0.92
Jan 15, 2026
recurring
Sep 30, 2025
$0.92
Oct 15, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.